Safety Rates Drug Report: adverse events in 2015 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
102563064	10256306	4	F	20130608	20150915	20140624	20150930	PER		US-CELGENEUS-163-21880-13064479	CELGENE		66.43	YR		M	Y	51.10000	KG	20150930	N	OT	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
102563064	10256306	1	PS	REVLIMID	LENALIDOMIDE	1	Oral	25 MILLIGRAM				U	UNKNOWN		21880	25	MG	CAPSULES	QD
102563064	10256306	2	SS	VELCADE	BORTEZOMIB	1	Subcutaneous	2 MILLIGRAM				U	102521		66188	2	MG	UNKNOWN

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
102563064	10256306	1	Plasma cell myeloma
102563064	10256306	2	Plasma cell myeloma

Outcome of event

Event ID	CASEID	OUTC COD
102563064	10256306	HO
102563064	10256306	OT

Reactions reported

Event ID	CASEID	PT
102563064	10256306	Hyporesponsive to stimuli
102563064	10256306	Lethargy
102563064	10256306	Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
102563064	10256306	1	20130402	20130608	0
102563064	10256306	2	20130402	20130607	0